Ovarian hyperstimulation syndrome after gonadotropin-releasing hormone agonist triggering and “freeze-all”: in-depth analysis of genetic predisposition

Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and “freeze-all” approach in GnRH antagonist protocol

(2014) Human Mousavi Fatemi et al.   FERTILITY AND STERILITY

GnRH agonist trigger and ovarian hyperstimulation syndrome: relook at ‘freeze-all strategy’

(2014) Liza Ping Ling et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study

(2013) S. Iliodromiti et al.   HUMAN REPRODUCTION

Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG

(2013) A. Seyhan et al.   HUMAN REPRODUCTION

Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation

(2013) Travis J O’Brien et al.   Reproductive Biology and Endocrinology

Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos

(2012) Juan A. Garcia-Velasco   FERTILITY AND STERILITY

Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support

(2012) Lawrence Engmann et al.   FERTILITY AND STERILITY

A case of severe early-onset OHSS after GnRH-agonist triggering

(2011) Shahar Kol   FERTILITY AND STERILITY

Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a “freeze-all” strategy: a prospective multicentric study

(2011) Georg Griesinger et al.   FERTILITY AND STERILITY

Agonist trigger: what is the best approach? Agonist trigger and low dose hCG

(2011) Peter Humaidan   FERTILITY AND STERILITY

An OHSS-Free Clinic by segmentation of IVF treatment

(2011) P. Devroey et al.   HUMAN REPRODUCTION

Genetic predictors of controlled ovarian hyperstimulation: where do we stand today?

(2011) S. Altmäe et al.   HUMAN REPRODUCTION UPDATE

GnRH agonist for triggering of final oocyte maturation: time for a change of practice?

(2011) P. Humaidan et al.   HUMAN REPRODUCTION UPDATE

Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome

(2010) Leyre Herrero et al.   FERTILITY AND STERILITY

A method and server for predicting damaging missense mutations

(2010) Ivan A Adzhubei et al.   NATURE METHODS

Genetics of ovarian hyperstimulation syndrome

(2010) Botros Rizk   REPRODUCTIVE BIOMEDICINE ONLINE

Ovarian hyperstimulation syndrome and complications of ART

(2009) Veerle Vloeberghs et al.   BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY

Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study

(2009) Daniel Bodri et al.   FERTILITY AND STERILITY

GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study

(2009) M Melo et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Follicle-stimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women

(2008) Swati K. Achrekar et al.   FERTILITY AND STERILITY

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study

(2007) Lawrence Engmann et al.   FERTILITY AND STERILITY